Analyst Coverage Update
Today, ROTH Capital Partners initiated coverage on SFE with a BUY Rating and a 12-Month Target Price of $16.50 Per Share. Safeguard Scientifics’ (NYSE: SFE)…
Posted by
Safeguard Insights
The Crazy Life of Business Development and Investor Relations – Part II
Back in February, I wrote a blog post summarizing my observations “from the road,” where we met with brokers, analysts and portfolio managers and shared…
Posted by
The Crazy Life of Business Development and Investor Relations
We’ve all had one of those weeks when you need to read the newspaper to remember what city you are in and what day it…
Posted by
